1-3 of 3
Anna Ferguson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

An Allogeneic Multiple Myeloma GM-CSF–Secreting Vaccine with Lenalidomide Induces Long-term Immunity and Durable Clinical Responses in Patients in Near Complete Remission

Luca Biavati, Carol Ann Huff, Anna Ferguson, Amy Sidorski, M. Amanda Stevens, Lakshmi Rudraraju, Cristina Zucchinetti, Syed Abbas Ali, Philip Imus, Christian B. Gocke, Rachel M. Gittelman, Sarah Johnson, Catherine Sanders, Marissa Vignali, Anita Gandhi, Xiaobu Ye, Kimberly A. Noonan, Ivan Borrello
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (24): 6696–6708.
https://doi.org/10.1158/1078-0432.CCR-21-1916
Published: 15 December 2021
View articletitled, An Allogeneic Multiple Myeloma GM-CSF–Secreting Vaccine with Lenalidomide Induces Long-term Immunity and Durable Clinical Responses in Patients in Near Complete Remission
Open the PDF for An Allogeneic Multiple Myeloma GM-CSF–Secreting Vaccine with Lenalidomide Induces Long-term Immunity and Durable Clinical Responses in Patients in Near Complete Remission in another window
Includes: Supplementary data
Journal Articles

A Multi-center Phase I Trial of Ipilimumab in Patients with Myelodysplastic Syndromes following Hypomethylating Agent Failure

Amer M. Zeidan, Hanna A. Knaus, Tara M. Robinson, Andrea M.H. Towlerton, Edus H. Warren, Joshua F. Zeidner, Amanda L. Blackford, Amy S. Duffield, David Rizzieri, Mark G. Frattini, Yair M. Levy, Mark A. Schroeder, Anna Ferguson, Katherine E. Sheldon, Amy E. DeZern, Ivana Gojo, Steven D. Gore, Howard Streicher, Leo Luznik, B. Douglas Smith
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (15): 3519–3527.
https://doi.org/10.1158/1078-0432.CCR-17-3763
Published: 31 July 2018
View articletitled, A Multi-center Phase I Trial of Ipilimumab in Patients with Myelodysplastic Syndromes following Hypomethylating Agent Failure
Open the PDF for A Multi-center Phase I Trial of Ipilimumab in Patients with Myelodysplastic Syndromes following Hypomethylating Agent Failure in another window
Includes: Supplementary data
Journal Articles

Lenalidomide-Induced Immunomodulation in Multiple Myeloma: Impact on Vaccines and Antitumor Responses

Kimberly Noonan, Lakshmi Rudraraju, Anna Ferguson, Amy Emerling, Marcela F. Pasetti, Carol A. Huff, Ivan Borrello
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (5): 1426–1434.
https://doi.org/10.1158/1078-0432.CCR-11-1221
Published: 01 March 2012
View articletitled, Lenalidomide-Induced Immunomodulation in Multiple Myeloma: Impact on Vaccines and Antitumor Responses
Open the PDF for Lenalidomide-Induced Immunomodulation in Multiple Myeloma: Impact on Vaccines and Antitumor Responses in another window
Includes: Supplementary data